Protagonist Therapeutics, Inc Marketable Securities (Non-Current)
Protagonist Therapeutics, Inc (PTGX) had Marketable Securities (Non-Current) of $66.88 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Marketable Securities, Noncurrent $66.88M.
- 2026-03-31: Marketable Securities, Noncurrent $72.55M.
- 2025-12-31: Marketable Securities, Noncurrent $78.64M.
- 2025-09-30: Marketable Securities, Noncurrent $102.70M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2026-06-30 | $66.88M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $72.55M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $78.64M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $102.70M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $102.49M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $123.52M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $140.25M 10-K · filed 2026-02-25 |
| 2024-09-30 | $114.56M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $31.45M 10-Q · filed 2024-08-06 |
| 2023-09-30 | $1.99M 10-Q · filed 2023-11-02 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-02 |
| 2021-09-30 | $38.17M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $26.12M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $6.25M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $2.00M 10-K · filed 2022-02-28 |
| 2020-09-30 | $6.03M 10-Q · filed 2020-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |